127 related articles for article (PubMed ID: 17309183)
1. Is there a role of whole body bone scan in early stages of non small cell lung cancer patients.
Iordanidou L; Trivizaki E; Saranti S; Georgakopoulos A; Bolanos N; Baltagiannis N; Koutsiouba P
J BUON; 2006; 11(4):491-7. PubMed ID: 17309183
[TBL] [Abstract][Full Text] [Related]
2. The role of whole-body bone scanning and clinical factors in detecting bone metastases in patients with non-small cell lung cancer.
Erturan S; Yaman M; Aydin G; Uzel I; Müsellim B; Kaynak K
Chest; 2005 Feb; 127(2):449-54. PubMed ID: 15705981
[TBL] [Abstract][Full Text] [Related]
3. Initial staging of non-small cell lung cancer: value of routine radioisotope bone scanning.
Michel F; Solèr M; Imhof E; Perruchoud AP
Thorax; 1991 Jul; 46(7):469-73. PubMed ID: 1652164
[TBL] [Abstract][Full Text] [Related]
4. Comparison of whole-body FDG-PET to bone scan for detection of bone metastases in patients with a new diagnosis of lung cancer.
Cheran SK; Herndon JE; Patz EF
Lung Cancer; 2004 Jun; 44(3):317-25. PubMed ID: 15140545
[TBL] [Abstract][Full Text] [Related]
5. Omission of bone scanning according to staging guidelines leads to futile therapy in non-small cell lung cancer.
Schirrmeister H; Arslandemir C; Glatting G; Mayer-Steinacker R; Bommer M; Dreinhöfer K; Buck A; Hetzel M
Eur J Nucl Med Mol Imaging; 2004 Jul; 31(7):964-8. PubMed ID: 14991241
[TBL] [Abstract][Full Text] [Related]
6. Bone metastases and lung cancer recurrence on (99m)Tc-depreotide imaging.
Meristoudis G; Ilias I; Batsakis C; Christakopoulou J
Hell J Nucl Med; 2008; 11(3):185-6, author reply 186. PubMed ID: 19081868
[No Abstract] [Full Text] [Related]
7. Suspected non-small cell lung cancer: incidence of occult brain and skeletal metastases and effectiveness of imaging for detection--pilot study.
Earnest F; Ryu JH; Miller GM; Luetmer PH; Forstrom LA; Burnett OL; Rowland CM; Swensen SJ; Midthun DE
Radiology; 1999 Apr; 211(1):137-45. PubMed ID: 10189463
[TBL] [Abstract][Full Text] [Related]
8. Detecting extrathoracic metastases in patients with non-small cell lung cancer: Is routine scanning necessary?
Metintas M; Ak G; Akcayir IA; Metintas S; Erginel S; Alatas F; Yildirim H; Kurt E; Ozkan R
Lung Cancer; 2007 Oct; 58(1):59-67. PubMed ID: 17566597
[TBL] [Abstract][Full Text] [Related]
9. Comparing whole body 18F-2-deoxyglucose positron emission tomography and technetium-99m methylene diophosphate bone scan to detect bone metastases in patients with non-small cell lung cancer.
Hsia TC; Shen YY; Yen RF; Kao CH; Changlai SP
Neoplasma; 2002; 49(4):267-71. PubMed ID: 12382027
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of pentavalent Tc-99m DMSA scintigraphy in small cell and nonsmall cell lung cancers.
Atasever T; Gündoğdu C; Vural G; Kapucu LO; Karalezli A; Unlü M
Nuklearmedizin; 1997 Oct; 36(7):223-7. PubMed ID: 9394361
[TBL] [Abstract][Full Text] [Related]
11. The role of Tc-99m (V) DMSA scintigraphy in the diagnosis and follow-up of lung cancer lesions.
Ergün EL; Kara PO; Gedik GK; Kars A; Türker A; Caner B
Ann Nucl Med; 2007 Jul; 21(5):275-83. PubMed ID: 17634845
[TBL] [Abstract][Full Text] [Related]
12. Non-small cell lung cancer staging: efficacy comparison of integrated PET/CT versus 3.0-T whole-body MR imaging.
Yi CA; Shin KM; Lee KS; Kim BT; Kim H; Kwon OJ; Choi JY; Chung MJ
Radiology; 2008 Aug; 248(2):632-42. PubMed ID: 18552311
[TBL] [Abstract][Full Text] [Related]
13. Bone turnover markers as predictors of skeletal complications in prostate cancer, lung cancer, and other solid tumors.
Brown JE; Cook RJ; Major P; Lipton A; Saad F; Smith M; Lee KA; Zheng M; Hei YJ; Coleman RE
J Natl Cancer Inst; 2005 Jan; 97(1):59-69. PubMed ID: 15632381
[TBL] [Abstract][Full Text] [Related]
14. [Importance of whole body skeletal scintigraphy within the scope of staging of neoplasms in the ENT area].
Piepenburg R; Bockisch A; Hach A; Steinert H; Welkoborsky HJ; Kreuz S; Mann WJ; Hahn K
Laryngorhinootologie; 1992 Dec; 71(12):605-10. PubMed ID: 1492886
[TBL] [Abstract][Full Text] [Related]
15. Staging non-small cell lung cancer with whole-body PET.
Marom EM; McAdams HP; Erasmus JJ; Goodman PC; Culhane DK; Coleman RE; Herndon JE; Patz EF
Radiology; 1999 Sep; 212(3):803-9. PubMed ID: 10478250
[TBL] [Abstract][Full Text] [Related]
16. Does whole-body 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography have an advantage over thoracic positron emission tomography for staging patients with lung cancer?
Aquino SL; Fischman AJ
Chest; 2004 Sep; 126(3):755-60. PubMed ID: 15364753
[TBL] [Abstract][Full Text] [Related]
17. Current diagnostic approaches in tumor-induced bone disease.
Sergieva S; Kirova G; Dudov A
J BUON; 2007; 12(4):493-504. PubMed ID: 18067208
[TBL] [Abstract][Full Text] [Related]
18. Mediastinal lymph node involvement in non-small cell lung cancer: evaluation with 99mTc-tetrofosmin SPECT and comparison with CT.
Schillaci O; Spanu A; Scopinaro F; Monteleone F; Solinas ME; Volpino P; Pirina P; Marongiu P; Cangemi V; Madeddu G
J Nucl Med; 2003 Aug; 44(8):1219-24. PubMed ID: 12902410
[TBL] [Abstract][Full Text] [Related]
19. Does initial staging or tumor histology better identify asymptomatic brain metastases in patients with non-small cell lung cancer?
Shi AA; Digumarthy SR; Temel JS; Halpern EF; Kuester LB; Aquino SL
J Thorac Oncol; 2006 Mar; 1(3):205-10. PubMed ID: 17409858
[TBL] [Abstract][Full Text] [Related]
20. FDG PET for staging of advanced non-small cell lung cancer prior to neoadjuvant radio-chemotherapy.
Eschmann SM; Friedel G; Paulsen F; Budach W; Harer-Mouline C; Dohmen BM; Bares R
Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):804-8. PubMed ID: 12029555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]